← Back to Search

Focused Ultrasound

ExABlate MR Guided Focus Ultrasound for Prostate Lesions

N/A
Waitlist Available
Led By Behfar Ehdaie, MD
Research Sponsored by InSightec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

The hypothesis of this study is that focal treatment with ExAblate MRgFUS has the potential to be an effective non-invasive treatment for intermediate risk, organ-confined prostate lesions, with a low incidence of morbidity. The study hypothesis will be tested by measuring treatment-related safety and initial effectiveness parameters in the ExAblate MRgFUS treated patients, as described above.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness of ExAblate MRgFUS focal treatment of intermediate risk organ-confined prostate lesions
Safety of ExAblate MRgFUS focal treatment of intermediate risk organ confined prostate lesions

Trial Design

1Treatment groups
Experimental Treatment
Group I: ExABlate MR Guided Focus UltrasoundExperimental Treatment1 Intervention
ExAblate MR Guided Focused Ultrasound - Local treatment of prostate lesions using Magnetic Resonance Imaging guided endorectally applied focused ultrasound energy.

Find a Location

Who is running the clinical trial?

InSightecLead Sponsor
88 Previous Clinical Trials
3,603 Total Patients Enrolled
Behfar Ehdaie, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions
2013. "Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01657942.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top